Dr. Jennifer Silva

St Louis Children’s Hospital

Jennifer N Avari Silva, MD, FHRS, FACC, FAHA

Director, Pediatric Electrophysiology, St Louis Children’s Hospital
Faculty Fellow in Entrepreneurship, Washington University in St Louis
Professor, Pediatrics and Biomedical Engineering, Washington University in St Louis

Co-Founder & Chief Medical Officer, Sentiar, Inc
Co-Founder & Consultant, Excera, Inc.

Jennifer Silva is Director of Pediatric Electrophysiology and a Professor of Pediatrics and Biomedical Engineering at Washington University School of Medicine/St. Louis Children’s Hospital, and serves as the Faculty Fellow in Entrepreneurship for Washington University SOM. She serves on committees within the Heart Rhythm Society (Chair, Women in Electrophysiology; Vice-Chair, Growth and Leadership Opportunity for Women in Electrophysiology; Production Team, HRX; Member, Membership Committee) and Pediatric and Congenital Electrophysiology Society (Member, Finance Committee), and serves on the NIH-SBIR study section for Cardiovascular Innovation. Jennifer also serves on the Editorial Board of Circulation: Arrhythmia and Electrophysiology, Heart Rhythm O2, and Cardiovascular Digital Health journals.

The scope of her research has been in innovation and emerging technologies with on developing and identifying clinical applications of new and emerging technologies within cardiac electrophysiology, particularly in the scope of wearable and advanced wearable technologies, including the extended realities.

Jennifer is the co-inventor and co-founder of SentiAR, Inc, a venture-backed software device spinout from Washington University which is developing the first mixed reality platform to display intraprocedural 3-dimensional holographic visualization of a patient’s cardiac anatomy with real time catheter locations with submission to the FDA in 2019. In 2018, the company received a NIH-SBIR award for $2.2M and in 2021 closed a $5.1M Series A Round. Most recently, she has co-founded a second company, Excera, Inc. which aims to improve outcomes for ultrasound-guided minimally invasive procedures. She has worked with several medical device companies including AliveCor, St Jude Medical/Abbott, Medtronic and Biosense Webster regarding development and implementation of novel technologies targeted to unmet clinical needs and development of regulatory pathways.


4:30pm - 5:00pm CST

Ballroom A Track 1

Advances in Medical Extended Reality in Cardiac Electrophysiology